Savara Inc. (SVRA) Financial Statements (2024 and earlier)

Company Profile

Business Address 6836 BEE CAVE ROAD
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments162,319,000168,251,000105,179,000114,777,000125,876,000134,077,000
Cash and cash equivalents26,585,00027,690,00022,745,00033,984,00052,100,000119,841,000
Short-term investments135,734,000140,561,00082,434,00080,793,00073,776,00014,236,000
Receivables191,000171,000200,000236,000162,000136,000
Prepaid expense176,000201,000221,000137,000231,000240,000
Other undisclosed current assets3,261,0001,473,0002,300,0002,476,0002,685,0002,616,000
Total current assets:165,947,000170,096,000107,900,000117,626,000128,954,000137,069,000
Noncurrent Assets
Operating lease, right-of-use asset 400,000400,000  100,000 
Property, plant and equipment270,000277,000264,00047,00051,00059,000
Other noncurrent assets387,0001,202,000888,000868,000116,000876,000
Other undisclosed noncurrent assets10,560,00010,097,00010,781,00010,818,00010,556,0009,754,000
Total noncurrent assets:11,617,00011,976,00011,933,00011,733,00010,823,00010,689,000
TOTAL ASSETS:177,564,000182,072,000119,833,000129,359,000139,777,000147,758,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,597,0008,963,0005,885,0004,922,0005,867,0006,778,000
Employee-related liabilities1,615,000
Accounts payable3,504,0003,219,0002,502,0001,573,0001,334,000893,000
Accrued liabilities7,093,0005,744,0003,383,0003,349,0004,533,0004,270,000
Other undisclosed current liabilities      (1,615,000)
Total current liabilities:10,597,0008,963,0005,885,0004,922,0005,867,0005,163,000
Noncurrent Liabilities
Long-term debt and lease obligation26,348,00026,281,00026,213,00026,145,00026,078,00026,010,000
Long-term debt, excluding current maturities26,348,00026,281,00026,213,00026,145,00026,078,00026,010,000
Liabilities, other than long-term debt247,000284,00020,00037,00054,00071,000
Other liabilities247,000284,00020,00037,00054,00071,000
Total noncurrent liabilities:26,595,00026,565,00026,233,00026,182,00026,132,00026,081,000
Total liabilities:37,192,00035,528,00032,118,00031,104,00031,999,00031,244,000
Equity
Equity, attributable to parent140,372,000146,544,00087,715,00098,255,000107,778,000116,514,000
Common stock140,000137,000116,000116,000116,000116,000
Additional paid in capital533,872,000524,619,000448,889,000447,828,000446,938,000446,376,000
Accumulated other comprehensive loss(271,000)(942,000)(619,000)(461,000)(605,000)(1,607,000)
Accumulated deficit(393,369,000)(377,270,000)(360,671,000)(349,228,000)(338,671,000)(328,371,000)
Other undisclosed equity(140,643,000)(147,486,000)(88,334,000)(98,716,000)(108,383,000)(118,121,000)
Total equity:(271,000)(942,000)(619,000)(461,000)(605,000)(1,607,000)
Other undisclosed liabilities and equity140,643,000147,486,00088,334,00098,716,000108,383,000118,121,000
TOTAL LIABILITIES AND EQUITY:177,564,000182,072,000119,833,000129,359,000139,777,000147,758,000

Income Statement (P&L) (USD)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Operating expenses(17,630,000)(18,044,000)(12,221,000)(12,112,000)(10,875,000)(10,535,000)
Operating loss:(17,630,000)(18,044,000)(12,221,000)(12,112,000)(10,875,000)(10,535,000)
Nonoperating income
(Other Nonoperating income)
1,531,0001,445,000778,0001,555,000575,000149,000
Loss from continuing operations:(16,099,000)(16,599,000)(11,443,000)(10,557,000)(10,300,000)(10,386,000)
Loss before gain (loss) on sale of properties:(10,386,000)
Net loss available to common stockholders, diluted:(16,099,000)(16,599,000)(11,443,000)(10,557,000)(10,300,000)(10,386,000)

Comprehensive Income (USD)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net loss:(16,099,000)(16,599,000)(11,443,000)(10,557,000)(10,300,000)(10,386,000)
Comprehensive loss:(16,099,000)(16,599,000)(11,443,000)(10,557,000)(10,300,000)(10,386,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent671,000(323,000)(158,000)144,0001,002,000(591,000)
Comprehensive loss, net of tax, attributable to parent:(15,428,000)(16,922,000)(11,601,000)(10,413,000)(9,298,000)(10,977,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: